Hims & Hers Reports Q3 Loss, Cuts Full-Year Profit Outlook
Hims & Hers Health reported a third-quarter net loss and reduced its full-year adjusted core profit guidance. Shares fell 3% after hours Monday; the report attributed the loss to a shift toward branded drugs from compounded ones.
Story updates
11:03:20 PM UTC
SquawkNews
Hims & Hers Health, Inc. announced its financial results for the third quarter of 2026, reporting revenue of $890.4 million, which fell slightly short of the FactSet consensus estimate of $893.1 million. The company reported a loss of $0.14 per share, missing the expected loss of $0.06 per share. Alongside these results, management provided updated guidance for the full year 2026, now projecting revenue between $3.13 billion and $3.15 billion, compared to the FactSet estimate of $3.21 billion. Additionally, the company issued a revenue outlook for the fourth quarter of 2026, expecting a range of $875.0 million to $895.0 million.
Shares of Hims & Hers Health Inc. fell 3% after hours on Monday after the telehealth provider reported a surprise third-quarter net loss, owing to a shift towards branded drugs in place of compounded ones, and reduced its full-year adjusted core profit guidance, raising investor concerns over softe…